As presented in Fig. 1C and D, of the 146 biopsies from ovarian cancer tested before (n=84, Fig. 1C–1 and C–2) and after (n=62, Fig. 1C–3) treatment, 90.47 and 56.6% of biopsies were positive for the protein C receptor, respectively. Here, PROCR is linked to ovarian carcinoma.